TABLE 1.
Clinical and demographic factors of 35 patients treated for tuberculosis in the Western Cape, South Africa
| Characteristic | Value |
|---|---|
| No. (%) of females | 23 (65.71) |
| Median age, yr (range) | 35 (20–71) |
| No. (%) self-identified as: | |
| Mixed-race South African | 31 (88.57) |
| Black South African | 4 (11.43) |
| Median body wt, kg (range) | 47.3 (30–68) |
| No. (%) HIV infected | 3 (8.57) |
| Median dose, mg/kg (range) | |
| Rifampin | 10.71 (8.38–15.00) |
| Isoniazid | 6.39 (4.41–10.00) |
| Pyrazinamide | 35.14 (19.69–50.00) |
| Ethambutol | 23.87 (12.88–30.77) |
| No. (%) with prior tuberculosis | 23 (65.71) |
| Median hemoglobin level, g/dl (range) | 12.00 (7.40–14.00) |
| Median white blood cell count, 109/ml (range) | 8.60 (3.80–25.70) |
| Median platelet count, 109 cells/ml (range) | 410.0 (66.0–813.0) |
| Median ESR,a mm/h (range) | 58 (12–136) |
| Median total protein level, g/liter (range) | 77 (62–92) |
| Median albumin level, g/liter (range) | 34.00 (21–43) |
a
ESR, erythrocyte sedimentation rate.